 |
Hematology |
 |
| Code |
Test Description
* Indicates send out test |
| T340 |
Crossmatch (recipient/donor) |
 |
| Specimen |
1 LT and 1 RT for recipient and 1 LT and 1 RT for donor |
 |
| Method |
RBC agglutination |
 |
| Schedule |
13 days |
 |
Interpretive Guidelines |
Agglutination or hemolysis indicates incompatibility with the donor. |
 |
| Indication |
Screen for host antibodies directed against antigens on the donor red cells. |
 |
| T345 |
Crossmatch (additional donor) |
 |
| Specimen |
1 LT and 1 RT for recipient and 1 LT and 1 RT for donor |
 |
| Method |
RBC agglutination |
 |
| Schedule |
13 days |
 |
| * S17501 |
Cytochemical Staining |
 |
| Specimen |
2 LT and 3 to 4 fresh peripheral blood smears. Trasnport in slide holders. |
 |
| Method |
Chloracetate esterase, non-specific esterase, myeloperoxidase, Sudan, CD markers (CD3, CD 79a) |
 |
| Schedule |
1014 days |
 |
| Indication |
Acute leukemia cell type characterization.
|
 |
| T350 |
D-Dimer |
 |
| Specimen |
1 BT or LT
Allow vacuum of citrate tubes to deliver correct amount of whole blood, centrifuge, separate and
place the citrated plasma in a tube with no anticoagulants or preservatives and cool. Please mark
the tube as citrated plasma on the label. |
 |
| Method |
Latex agglutination |
 |
| Schedule |
Daily |
 |
 |
| Indication |
Evaluation of coagulation disorders and investigation of possible DIC |
 |
Interpretive Guidelines |
Increase values supports a diagnosis of DIC. |
 |
Reference Ranges |
| Normal |
< 250 mg/dl |
| Mild elevation |
250500 mg/dl |
| Moderate elevation |
5001000 mg/dl |
| Marked elevation |
10002000 mg/dl |
| Severe elevation |
> 2000 mg/dl |
|
 |
 |
| Comments |
Values of 250500 mg/dl may be seen in the post-surgical period. |
 |
| T540 |
Direct Coombs' |
 |
| Specimen |
1 LT |
 |
 |
| Method |
Agglutination |
 |
| Schedule |
12 days |
 |
 |
| Indication |
Investigation of autoimmune hemolytic anemia (AIHA) |
 |
Interpretive Guidelines |
A positive test, in conjunction with appropriate clinical signs, is supportive of immune mediated hemolysis. |
 |
Reference Ranges |
Negative |
 |
| * S16290 |
Erythropoietin |
 |
| Specimen |
1 ml frozen serum or EDTA plasma.
Frozen: stable for 2 months at -20ºC |
 |
| Schedule |
710 days |
 |
 |
| Indication |
Evaluation of polycythemia |
 |
Interpretive Guidelines |
Suppressed erythropoietin concentration in the presence of polycythemia supports a diagnosis
of primary polycythemia (polycythemia vera). Normal or increased concentration indicates a secondary cause for
polycythemia (hypoxia, renal cyst or tumor, hydronephrosis). This assay can also used in the evaluation of chronic
renal disease, nonregenerative anemias and detect exogenous administration of EPOGEN. |
 |
| * S17509 |
Anti-Erythropoietin AB |
 |
| Specimen |
Serum |
 |
| Method |
ELISA |
 |
| Schedule |
510 days |
 |
| Indication |
Detection of equine antibodies against human recombinant erythropoietin. |
 |
Interpretive Guidelines |
A positive result implies previous exposure to hurEPO and exogenous erythropoietin administration. |
 |
| T365 |
Fibrinogen |
 |
| Specimen |
1 BT (Preferred) or 1 LT within 24-hours of collection |
 |
| Method |
Automated |
 |
| Schedule |
Daily |
 |
| Indication |
Indirect indicator of inflammation. |
 |
Interpretive Guidelines |
Fibrinogen levels increase in proportion to the severity and localized nature of the inflammatory
process. Fibrinogen levels can decrease with DIC and hepatic failure. |
 |
 |
 |
|
|
 |
Please send comments to the webmaster.
©1997-2008 Antech Diagnostics, Inc.
Site design and maintenance by amesDesign. |